コレストロールAPI市場：現状分析および予測（2022年～2028年）

世界のコレストロールAPIの市場規模は、予測期間中に約4.8%の成長率で拡大すると予測されています。ドラッグデリバリーシステムにおけるリポソーム製剤の使用の増加は、世界中でコレストロールAPIの売上を押し上げるとみられています。

当レポートは、世界のコレストロールAPI市場について調査し、市場の概要とともに、由来別、製造プロセス別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場イントロダクション

第2章 調査方法または仮定

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 コレステロールAPI市場に対するCOVID-19の影響

第6章 コレステロールAPI市場の収益（10億米ドル）、2020年～2028年

第7章 由来別の市場洞察

• 動物由来
• 植物由来
• 合成

第8章 製造プロセス別の市場洞察

• GMP
• 非GMP

第9章 エンドユーザー別の市場洞察

• RNAワクチン
• モノクローナル抗体
• その他

第10章 地域別の市場洞察

• 北米
• 欧州
• アジア太平洋
• その他の地域

第11章 コレステロールAPI市場の市場力学

• 市場促進要因
• 市場の課題
• 影響分析

第12章 コレステロールAPIの市場機会

第13章 コレストロールAPIの市場動向

第14章 需要側と供給側の分析

第15章 バリューチェーン分析

第16章 競合シナリオ

第17章 会社概要

• Merck KGaA
• Cayman Chemical
• CordenPharma International
• Croda International Plc
• NOF CORPORATION
• Nippon Fine Chemical Co., Ltd.
• Akums
• Tokyo Chemical Industry Co., Ltd.
• Evonik Industries AG
• CARBOGEN AMCIS

第18章 免責事項

Global Cholesterol API Market is expected to grow at a significant rate of around 4.8% during the forecast period. Cholesterol is the most used sterol in the formulation of liposomes which can prevent liposome aggregation and improve the liposomal membrane's stability. Cholesterol plays a crucial role in the stability of a liposomal membrane. Thus, the rising use of liposomal formulations in drug delivery systems is set to boost sales of cholesterol APIs across the globe. Moreover, Cholesterol API is found in the lipid shells used in the production of RNA vaccines, giving the vaccine exceptional stability by halting the activity of enzyme breakdown. They are often derived from plants and animals, although they can also be chemically manufactured in laboratories. For instance, in March 2022, Croda International Plc, announced the support of the UK government to the expansion of its manufacturing facility which is estimated to boost the development of high-purity lipid systems for next-generation nucleic acid drugs such as mRNA vaccines. Thus, the above-mentioned factors drive the cholesterol API market.

Merck KGaA, Cayman Chemical, CordenPharma International, Croda International Plc, NOF CORPORATION, Nippon Fine Chemical Co., Ltd., Akums, Tokyo Chemical Industry Co., Ltd., Evonik Industries AG, CARBOGEN AMCIS are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst source, animal-derived held a significant share in the market in 2020"

Based on source, the market is segmented into animal-derived, plant-derived, and synthetic. The animal-derived category held a significant market share in 2020. Plant-derived bioactive compounds, often called phytochemicals, are active substances extracted from different plants. Plant-derived cholesterol is becoming more and more in demand. For instance, in 2021, Evonik Industries AG, Phytochol® is a plant-derived cholesterol for mRNA delivery, gene therapy, and cell culture. Cholesterol is an important functional excipient for parenteral mRNA-based drug delivery systems.

"Amongst end user, the RNA vaccines held a significant CAGR during the forecast period"

On the basis of end user, the market is categorized into RNA vaccines, monoclonal antibodies, and others. Among these, RNA vaccines held a significant CAGR during the forecast period. This is mainly due to the cholesterol-lowering vaccine could help tackle heart disease. RNA-Cholesterol nanoparticles function as potent immune activators via TLR7 and TLR8. The innate immune system senses viral and bacterial ribonucleic acid (RNA) via pattern recognition receptors (PRR) leading to subsequent activation of the immune system.

"APAC held a significant share in the market"

In 2020, APAC held a significant share of the global cholesterol API market. This is mainly attributed to the presence of multiple domestic and foreign API producers in China as well as their ongoing investments in the globalization of supply chains are credited with the industry's growth. The market will be driven by the presence of multiple generic API producers in India as well as the development of that nation's pharmaceutical sector. In addition, a big number of foreign companies are expected to enter the Indian market as a result of the availability of labor and raw commodities that are reasonably inexpensive. The region's bioprocess industry is also anticipated to drive up demand for cholesterol APIs.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global cholesterol API market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Cholesterol API Market
• 2.2. Research Methodology of the Cholesterol API Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE CHOLESTEROL API MARKET

6 CHOLESTEROL API MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY SOURCE

• 7.1. Animal Derived
• 7.2. Plant Derived
• 7.3. Synthetic

8 MARKET INSIGHTS BY MANUFACTURING PROCESS

• 8.1. Good Manufacturing Practice (GMP)
• 8.2. Non - GMP

9 MARKET INSIGHTS BY END-USER

• 9.1. RNA Vaccines
• 9.2. Monoclonal Antibodies
• 9.3. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Rest of Asia-Pacific
• 10.4. Rest of World

11 CHOLESTEROL API MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 CHOLESTEROL API MARKET OPPORTUNITIES

13 CHOLESTEROL API MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

• 16.1. Competitive Landscape
  • 16.1.1. Porters Five Forces Analysis

17 COMPANY PROFILED

• 17.1. Merck KGaA
• 17.2. Cayman Chemical
• 17.3. CordenPharma International
• 17.4. Croda International Plc
• 17.5. NOF CORPORATION
• 17.6. Nippon Fine Chemical Co., Ltd.
• 17.7. Akums
• 17.8. Tokyo Chemical Industry Co., Ltd.
• 17.9. Evonik Industries AG
• 17.10. CARBOGEN AMCIS

18 DISCLAIMER